158 related articles for article (PubMed ID: 25443745)
1. On the toxicity of kynurenic acid in vivo and in vitro.
Turski WA; Małaczewska J; Marciniak S; Bednarski J; Turski MP; Jabłoński M; Siwicki AK
Pharmacol Rep; 2014 Dec; 66(6):1127-33. PubMed ID: 25443745
[TBL] [Abstract][Full Text] [Related]
2. Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord.
Dabrowski W; Kwiecien JM; Rola R; Klapec M; Stanisz GJ; Kotlinska-Hasiec E; Oakden W; Janik R; Coote M; Frey BN; Turski WA
PLoS One; 2015; 10(11):e0142598. PubMed ID: 26562835
[TBL] [Abstract][Full Text] [Related]
3. Long-term systemic administration of kynurenic acid brain region specifically elevates the abundance of functional CB
Zádor F; Nagy-Grócz G; Dvorácskó S; Bohár Z; Cseh EK; Zádori D; Párdutz Á; Szűcs E; Tömböly C; Borsodi A; Benyhe S; Vécsei L
Neurochem Int; 2020 Sep; 138():104752. PubMed ID: 32445659
[TBL] [Abstract][Full Text] [Related]
4. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
[TBL] [Abstract][Full Text] [Related]
5. Preferential Disruption of Prefrontal GABAergic Function by Nanomolar Concentrations of the α7nACh Negative Modulator Kynurenic Acid.
Flores-Barrera E; Thomases DR; Cass DK; Bhandari A; Schwarcz R; Bruno JP; Tseng KY
J Neurosci; 2017 Aug; 37(33):7921-7929. PubMed ID: 28729445
[TBL] [Abstract][Full Text] [Related]
6. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
[TBL] [Abstract][Full Text] [Related]
7. G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast.
Cosi C; Mannaioni G; Cozzi A; Carlà V; Sili M; Cavone L; Maratea D; Moroni F
Neuropharmacology; 2011 Jun; 60(7-8):1227-31. PubMed ID: 21110987
[TBL] [Abstract][Full Text] [Related]
8. Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro.
Di Serio C; Cozzi A; Angeli I; Doria L; Micucci I; Pellerito S; Mirone P; Masotti G; Moroni F; Tarantini F
Cell Mol Neurobiol; 2005 Sep; 25(6):981-93. PubMed ID: 16392031
[TBL] [Abstract][Full Text] [Related]
9. Fate and distribution of kynurenic acid administered as beverage.
Turska M; Pelak J; Turski MP; Kocki T; Dukowski P; Plech T; Turski W
Pharmacol Rep; 2018 Dec; 70(6):1089-1096. PubMed ID: 30308459
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
[TBL] [Abstract][Full Text] [Related]
11. Chronic dietary supplementation with kynurenic acid, a neuroactive metabolite of tryptophan, decreased body weight without negative influence on densitometry and mandibular bone biomechanical endurance in young rats.
Tomaszewska E; Muszyński S; Kuc D; Dobrowolski P; Lamorski K; Smolińska K; Donaldson J; Świetlicka I; Mielnik-Błaszczak M; Paluszkiewicz P; Parada-Turska J
PLoS One; 2019; 14(12):e0226205. PubMed ID: 31809528
[TBL] [Abstract][Full Text] [Related]
12. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.
Hilmas C; Pereira EF; Alkondon M; Rassoulpour A; Schwarcz R; Albuquerque EX
J Neurosci; 2001 Oct; 21(19):7463-73. PubMed ID: 11567036
[TBL] [Abstract][Full Text] [Related]
13. Kynurenic Acid Induces Impairment of Oligodendrocyte Viability: On the Role of Glutamatergic Mechanisms.
Langner E; Lemieszek MK; Kwiecień JM; Rajtar G; Rzeski W; Turski WA
Neurochem Res; 2017 Mar; 42(3):838-845. PubMed ID: 27444613
[TBL] [Abstract][Full Text] [Related]
14. Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells.
Walczak K; Deneka-Hannemann S; Jarosz B; Zgrajka W; Stoma F; Trojanowski T; Turski WA; Rzeski W
Pharmacol Rep; 2014 Feb; 66(1):130-6. PubMed ID: 24905318
[TBL] [Abstract][Full Text] [Related]
15. The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction.
Klein C; Patte-Mensah C; Taleb O; Bourguignon JJ; Schmitt M; Bihel F; Maitre M; Mensah-Nyagan AG
Neuropharmacology; 2013 Jul; 70():254-60. PubMed ID: 23422298
[TBL] [Abstract][Full Text] [Related]
16. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
[TBL] [Abstract][Full Text] [Related]
17. Kynurenic acid as the neglected ingredient of commercial baby formulas.
Milart P; Paluszkiewicz P; Dobrowolski P; Tomaszewska E; Smolinska K; Debinska I; Gawel K; Walczak K; Bednarski J; Turska M; Raban M; Kocki T; Turski WA
Sci Rep; 2019 Apr; 9(1):6108. PubMed ID: 30988385
[TBL] [Abstract][Full Text] [Related]
18. Presence of kynurenic acid in food and honeybee products.
Turski MP; Turska M; Zgrajka W; Kuc D; Turski WA
Amino Acids; 2009 Jan; 36(1):75-80. PubMed ID: 18231708
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of kynurenic acid, a tryptophan metabolite, and its derivatives on cytosolic sulfotransferases.
Senggunprai L; Yoshinari K; Yamazoe Y
Biochem J; 2009 Aug; 422(3):455-62. PubMed ID: 19548878
[TBL] [Abstract][Full Text] [Related]
20. Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells.
Wejksza K; Rzeski W; Turski WA
Pharmacol Rep; 2009; 61(4):751-6. PubMed ID: 19815960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
